Stockreport

Entrada Therapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Entrada Therapeutics, Inc.  (TRDA) 
PDF US$0.34 loss per share (down from US$1.07 profit in 3Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analy [Read more]